Kröger, N. Et Al. 2021. Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study. 47TH ANNUAL MEETING OF EBMT , 143-144.

Kröger, N., Sbıanchı, G., Sıraıt, T., Beelen, D., Passweg, J., Robın, M., ... Vrhovac, R.(2021). Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study . 47TH ANNUAL MEETING OF EBMT (pp.143-144).

Kröger, Nıcolaus Et Al. "Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study," 47TH ANNUAL MEETING OF EBMT, 2021

Kröger, Nıcolaus Et Al. "Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study." 47TH ANNUAL MEETING OF EBMT , pp.143-144, 2021

Kröger, N. Et Al. (2021) . "Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study." 47TH ANNUAL MEETING OF EBMT , pp.143-144.

@conferencepaper{conferencepaper, author={Nıcolaus Kröger Et Al. }, title={Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study}, congress name={47TH ANNUAL MEETING OF EBMT}, city={}, country={}, year={2021}, pages={143-144} }